Deborah van de Wal, MD

PhD candidate
Netherlands Cancer Institute/ Antoni van Leeuwenhoek, Netherlands

My name is Deborah, I am a PhD student at the NKI in the Netherlands. My PhD focusses on health-related quality of life of GIST patients, specifically advanced and metastatic GIST patients responding to long-term tyrosine kinase inhibitor (TKI) treatment. After I finished my medical school and before I started my PhD, I worked in several hospitals as resident not in training, but I hope to become an oncologist one day.

Poster(s):

• (P 30) FINANCIAL DIFFICULTIES EXPERIENCED BY DUTCH GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS: DATA FROM A CROSS-SECTIONAL MULTICENTER STUDY

• (P 31) NEOADJUVANT IMATINIB IN LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) IS EFFECTIVE AND SAFE: RESULTS FROM A PROSPECTIVE SINGLE CENTER STUDY WITH 108 PATIENTS